Reklāma

FSTX Forex ziņas

F-star Therapeutics Inks License Deal With Takeda To Develop Bispecific Antibody

Biopharmaceutical company F-star Therapeutics, Inc. (FSTX), operating through its subsidiary, F-star Therapeutics Ltd., announced Wednesday that it has entered into a license agreement with Japan's Takeda Pharmaceutical Co. Ltd. (TAK) to develop a bispecific antibody.

RTTNews | 1123 days ago

Noteikumi | Privātums | Lapas karte | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.1698	GBPUSD	1.3551	AUDUSD	0.6504
USDJPY	147.18	USDCAD	1.38173	USDCHF	0.8063